https://www.zacks.com/stock/news/2271405/are-investors-undervaluing-ci-financial-cixxf-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2271405
May 09, 2024 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
zc:7960712334307369132
0
https://www.zacks.com/stock/news/2269942/select-medical-s-sem-shares-up-12-9-since-q1-earnings-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-2269942
May 07, 2024 - Select Medical (SEM) revises its adjusted EBITDA guidance upward between $845 million and $885 million for 2024, the mid-point is higher than $807.4 million in 2023.
zc:6972985295800910859
0
https://www.zacks.com/stock/news/2269026/acadia-healthcare-achc-shares-down-9-despite-q1-earnings-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-2269026
May 06, 2024 - Acadia Healthcare's (ACHC) Q1 results aided by improved revenue per patient day, partly offset by escalating costs. It continues to expect 2024 adjusted EPS within $3.40-$3.70.
zc:-2497324070634926759
0
https://www.fool.com/investing/2024/05/03/how-to-win-in-business-be-right-be-positive/?source=iedfolrf0000001
May 03, 2024 - Author Elliott Parker helps us think about how to spot the difference between world-changing innovations and corporate theater.
0
fool:-6402214869561898063
0
https://www.zacks.com/commentary/2267710/4-hmo-stocks-to-watch-amid-persistent-industry-challenges?cid=CS-ZC-FT-industry_outlook-2267710
May 03, 2024 - The Medical-HMO industry continues to witness an expanding customer base resulting from contract wins. However, high technology expenses and a shortage of medical personnel are a concern. UNH, CI, CNC and HUM are likely to navigate industry storms.
zc:-4910032991829822807
0
https://www.zacks.com/stock/news/2267380/compared-to-estimates-cigna-ci-q1-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2267380
May 02, 2024 - Although the revenue and EPS for Cigna (CI) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
zc:-1585039585826063619
0
https://www.zacks.com/stock/news/2267361/cigna-ci-q1-earnings-beat-on-client-wins-in-evernorth-unit?cid=CS-ZC-FT-analyst_blog|earnings_article-2267361
May 02, 2024 - Cigna's (CI) Q1 results reflect strong organic growth in the Evernorth Health Services unit. It expects adjusted EPS of at least $28.40 for 2024, up from the earlier guidance of at least $28.25.
zc:3047771712818341818
0
https://www.zacks.com/stock/news/2265281/analyzing-how-you-should-play-cigna-ci-ahead-of-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2265281
Apr 30, 2024 - The first-quarter results of Cigna (CI) are likely to reflect expanding commercial middle market memberships and growth in Cigna Healthcare profits.
zc:3984282653518172956
0
https://www.zacks.com/stock/news/2260671/cigna-ci-stock-dips-while-market-gains-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v2-2260671
Apr 23, 2024 - In the closing of the recent trading day, Cigna (CI) stood at $352.65, denoting a -0.15% change from the preceding trading day.
zc:-3475132770004487450
0
https://www.zacks.com/stock/news/2258100/ci-financial-corp-cixxf-flat-as-market-sinks-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v3-2258100
Apr 18, 2024 - CI Financial Corp. (CIXXF) concluded the recent trading session at $11.83, signifying no movement from its prior day's close.
zc:-1012569022838105422
0